• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400488 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2024-07-27 Suzhou Suncadia Biopharmaceuticals Co Ltd view
CYSB2400183 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-07-18 Shanghai Henlius Biopharmaceutical Co Ltd view
JYSB2400153 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-07-16 view
CYSB2400153 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-06-14 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CYSB2400103 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-05-01 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CYSB2400104 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-05-01 Shandong BoAn Biotechnology Co Ltd view
CXSL2400202 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2024-03-23 Bio-Thera Solutions Ltd view
CXSL2400201 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2024-03-23 Bio-Thera Solutions Ltd view
JYSB2400036 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-02-28 view
CXSS2400010 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2024-01-17 SinoCelltech Ltd view
CYSB2300206 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-11-04 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300202 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-10-31 Bio-Thera Solutions Ltd view
CYSB2300201 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-10-31 Bio-Thera Solutions Ltd view
CYSB2300174 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-09-26 TOT Biopharm Co Ltd view
CYSB2300146 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-07-27 QILU Pharmaceutical Co Ltd view
CXSS2300058 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2023-07-26 Shanghai Institute of Biological Products Co Ltd view
CXSS2300048 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2023-07-03 Hualan Genetic Engineering Co Ltd view
JXSL2300111 眼用贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) Import Drug Application 2023-06-20 view
CYSB2300112 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-06-12 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSL2300357 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2023-05-19 Bio-Thera Solutions Ltd view